Authors


Paige Nong, BA

Latest:

Integrating Predictive Models Into Care: Facilitating Informed Decision-Making and Communicating Equity Issues

As predictive models proliferate, providers and decision makers require accessible information to guide their use. Preventing and combating bias must also be priorities in model development and in communication with providers and decision makers.


Mason R. Goodman, MD

Latest:

An Outpatient Critical Care Transition Clinic Model Reduces Admissions/Readmissions in Medically Complex Patients

Critical care transition clinic patients with chronic conditions had a 31% reduction in relative risk for inpatient admissions, and the clinic reduced cost by more than $1 million.


Donald Deep, MD

Latest:

Managing Total Knee Replacement Under Value-Based Payments

This article describes the approach that a large primary care group at risk for value-based payments chose to deploy in managing clinical and financial outcomes of knee osteoarthritis jointly with orthopedic surgeons.


Byoung Chul Cho, MD, PhD

Latest:

Enhanced Prophylactic Regimen Reduces Skin AEs With Amivantamab-Lazertinib: Byoung Chul Cho, MD, PhD

Byoung Chul Cho, MD, PhD, of the Yonsei University College of Medicine, discussed outcomes in the COCOON trial of an enhanced dermatologic regimen with amivantamab-lazertinib treatment.


Jee H. Choe, MS

Latest:

Medication Persistence and Its Impact on Type 2 Diabetes

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.


Tamsin Zandstra, MA

Latest:

Long-Term Health Care Costs Following COVID-19: Implications for Pandemic Preparedness

A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.


Darren Wheeler, MD

Latest:

Reducing Delays in Breast Cancer Care Using an Innovative Digital Health Platform

The use of a novel digital health platform achieved a 55% reduction in time to treatment among women with a new diagnosis of breast cancer.


LaVarne A. Burton

Latest:

Contributor: Medicare Policy Proposal Jeopardizes Care for Those on Dialysis

CEOs of 3 kidney care organizations explain flaws in CMS' recent reimbursement proposal.


Paul M. Coplan, PhD, MBA

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Eric Kwok, BS

Latest:

Modeling Financial Outcomes and Quantifying Risk in Episode-Based Payment Models

This article provides a description of prospective financial simulation methodology and use cases with empirical data for episode-based bundled payments, including implications for contract negotiations and value-based care redesign.


Esther Adeniran, DrPH

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.


Dr Michael A. Bernstein | Image Credit: Stamford Health
Michael A. Bernstein, MD

Latest:

Kansas City’s TB Outbreak Can Be Contained With the Lessons From COVID-19

In this final interview clip, Michael A. Bernstein, MD, stresses the need for effective communication and proactive screening to contain the ongoing tuberculosis (TB) outbreak in Kansas City.


Marry Vuong, PharmD, BCPPS

Latest:

Follow-Up and Monitoring: Proactive Strategies for Long-Term Patient Engagement After Hidradenitis Suppurativa Diagnosis

Panelists discuss the critical role of effective follow-up and multidisciplinary care in managing hidradenitis suppurativa, emphasizing ongoing patient education, coordinated referrals, and personalized treatment plans to improve adherence and long-term outcomes.


Jake Haselswerdt, PhD

Latest:

Provider Capacity During Medicaid Expansion and a Public Health Emergency

This survey study finds that most Missouri Medicaid providers had capacity for new patients, even during a period of unprecedented Medicaid enrollment growth.


Alexander Beschloss, MD, MBA

Latest:

Contributor: Roadmap to the Quadruple Aim—A Framework for Minimizing Physician Burnout During the Transition to Value-Based Care

As provider and payer organizations pursue the Quadruple Aim, it is important that they take into account not just the contracting but also the transformation in staffing, clinical workflows, and culture as these organizations evolve.


Elena Andreyeva, PhD

Latest:

Affordable Care Act Enrollment in Texas After Rating Area Adjustments

Rural marketplace rating area change in Texas did not increase enrollment but increased share of enrollment in gold plans.


Jason Porter, MD

Latest:

ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions

Jason Porter, MD, provides concluding insights on the LAURA phase 3 trial, CHRYSALIS-2 study, TROPION-Lung05 trial, and CheckMate 9LA study, along with other notable findings from the ASCO 2024 conference.


Adam J. Milam, MD, PhD

Latest:

Understanding the Complexities of Equity Within the Emergence and Utilization of AI in Academic Medical Centers

This editorial discusses positions for academic medical centers to consider when designing and implementing artificial intelligence (AI) tools.


Wendy K. Chung, MD, PhD

Latest:

Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.


Tam Dang-Tan, PhD

Latest:

Glucose-Lowering Treatment Patterns in Patients With Diabetic Kidney Disease

Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.



Kanaka D. Shetty, MD, MS

Latest:

Actions to Improve Quality: Results From a National Hospital Survey

Hospitals reported widespread adoption of quality improvement (QI) changes to improve on CMS quality measures, and QI adoption was associated with improved performance on quality measures.


Minakshi Raj, PhD, MPH

Latest:

Characterizing Telehealth Use in the US: Analysis of the 2022 Health Information National Trends Survey

Patients’ motivations for telehealth use require further investigation to develop appropriate policies.


Michael Ashley Stein | Image credit: Harvard Law School
Michael Ashley Stein, PhD, JD

Latest:

Q&A: Dr Michael Ashley Stein Speaks on How Natural Disasters Can Affect Disabled Individuals

Michael Ashley Stein, PhD, JD, speaks about how disabled individuals are at a disadvantage when it comes to preparing for natural disasters, specifically during wildfires.


Saria Awadalla, PhD

Latest:

Adherence Patterns 1 Year After Initiation of SGLT2 Inhibitors: Results of a National Cohort Study

This article describes the trajectory of adherence patterns among users of sodium-glucose cotransporter 2 (SGLT2) inhibitors. The authors found that baseline factors were unable to predict the adherence trajectory groups.


Sancia K. Ferguson, MD, MPH

Latest:

Organizational Factors Associated With Variation in Primary Care Providers in ACOs

A higher percentage of accountable care organization (ACO) primary care providers was associated with physician leadership, upside financial risk, and financial compensation of physicians tied to performance measures.



Anders H. Nyberg, MD, PhD

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Aaron Brice, MD

Latest:

Telehealth User Experiences During COVID-19: A Case Study of Outpatient Cardiovascular Clinics Affiliated With a Large Academic Practice

In cardiovascular clinics during COVID-19, notable barriers to successful telehealth use included obtaining diagnostic information needed to deliver high-quality care and technology-related challenges for patients.


Edward Li, PharmD, MPH

Latest:

Budget Impact Analysis of Biosimilar Natalizumab in the US

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo